| Home | E-Submission | Sitemap | Contact Us |  
Korean J Intern Med Search > Browse Articles > Korean J Intern Med Search



Pulmonology
Combination of carboplatin and intermittent normobaric hyperoxia synergistically suppresses benzo[a]pyrene-induced lung cancer
Korean J Intern Med. 2018;33(3):541-551.   Published online December 15, 2017
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer
Korean J Intern Med. 2017;32(5):923-925.   Published online March 18, 2017
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Gender Differences in Susceptibility to Smoking among Patients with Lung Cancer
Korean J Intern Med. 2011;26(4):427-431.   Published online November 28, 2011
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer
Korean J Intern Med. 2011;26(3):304-313.   Published online September 13, 2011
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Endoscopic Cryotherapy of Lung and Bronchial Tumors: A Systematic Review
Korean J Intern Med. 2011;26(2):137-144.   Published online June 1, 2011
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Primary Pulmonary Biphasic Synovial Sarcoma Confirmed by Molecular Detection of a SYT-SSX2 Fusion Gene: Report of 1 Case
Korean J Intern Med. 2010;25(3):331-336.   Published online August 31, 2010
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
Korean J Intern Med. 2010;25(3):294-300.   Published online August 31, 2010
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Two Lung Masses with Different Responses to Pemetrexed
Korean J Intern Med. 2010;25(2):213-216.   Published online June 1, 2010
Full Text     PubReader     ePub     CrossRef - TDM     PDF
Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
Received January 7, 2018  Accepted March 27, 2018  Published online June 29, 2018
DOI: https://doi.org/10.3904/kjim.2018.011    [Epub ahead of print]
Full Text     PubReader     ePub     CrossRef - TDM     PDF     Supplementary
Author's Index
Impact factor
SCImago Journal & Country Rank
crossref CITEDBY
CrossMark
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
Copyright © 2018 The Korean Association of Internal Medicine. All rights reserved.
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
powerd by m2community